Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

Lowie Vanfleteren,1–3 Leonardo M Fabbri,1,4 Alberto Papi,4 Stefano Petruzzelli,5 Bartolome Celli6 1COPD Center, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden; 2CIRO, Horn, the Netherlands; 3Department of Respiratory Medicine, Maastric...

Full description

Bibliographic Details
Main Authors: Vanfleteren L, Fabbri LM, Papi A, Petruzzelli S, Celli B
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:International Journal of COPD
Subjects:
Muscarinic antagonists
adrenergic beta-2 receptor agonists
glucocorticoids
pulmonary disease
chronic obstructive
review
exacerbations
safety
Online Access:https://www.dovepress.com/triple-therapy-icslabalama-in-copd-time-for-a-reappraisal-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/triple-therapy-icslabalama-in-copd-time-for-a-reappraisal-peer-reviewed-article-COPD

Similar Items